MedPath

Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery

Phase 3
Completed
Conditions
Opioid Use, Unspecified
Bariatric Surgery Candidate
Anesthesia
Interventions
Drug: Opioid Anesthetics
Drug: Non Opioid Analgesics
Registration Number
NCT04081545
Lead Sponsor
Christine Oryhan
Brief Summary

A comparison of post-operative opioid use in laparoscopic bariatric surgery patients receiving opioid or opioid-free anesthesia.

Detailed Description

This is a prospective, single-center, single-blinded, randomized controlled trial comparing the effect of an opioid-free general anesthetic versus a traditional anesthetic with a restricted quantity of opioid on postoperative opioid consumption following laparoscopic bariatric surgery. The study population will be composed of 196 subjects undergoing laparoscopic bariatric surgery at Virginia Mason Medical center randomized into two groups. The control group will receive a traditional opioid restrictive general anesthetic. The study group will receive an opioid-free anesthetic technique.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
181
Inclusion Criteria
  • Adult patients undergoing elective laparoscopic bariatric surgery (i.e. laparoscopic roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy) able to provide informed consent
Exclusion Criteria
  • Any opioid use within 4 weeks prior to surgery
  • Chronic antiemetic use
  • Conversion of laparoscopic to open surgery
  • Patients unable to provide post-operative pain scores
  • Pregnant or lactating patients
  • Patients under 18 years of age
  • Refusal or inability to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control Goup A- Opioid-based regimenOpioid AnestheticsPreop - Multimodals unless contraindicated Induction * Fentanyl (50mcg IV) * Lidocaine 1.5mg/kg IV bolus using IBW (Ideal body weight) * Propofol 2-3mg/kg IV bolus * Neuromuscular blockade per Anesthesiology team discretion Maintenance * Sevoflurane * Neuromuscular blockade at discretion of anesthesiology team * May use fentanyl to treat SBP or HR \> 20% of baseline Emergence * Neuromuscular reversal, dosed according to Virginia Mason protocol * May titrate fentanyl per anesthesiology team throughout the case. * Patient extubated and brought to PACU PACU opioid orders per anesthesiology team Post-operative Nausea/Vomiting Prophylaxis -4mg dexamethasone, 1mg haloperidol, scopolamine patch
Experimental Group B- Opioid-free regimenNon Opioid AnalgesicsPreop - Multimodals unless contraindicated Induction * Dexmedetomidine 1mcg/kg IV bolus over 10 minutes using IBW * Lidocaine 1.5mg/kg IV bolus using IBW * Propofol 2-3mg/kg IV bolus * Neuromuscular blockade per Anesthesiology team discretion * Ketamine 0.5mg/kg IV bolus (based on IBW) Maintenance * Sevoflurane * Dexmedetomidine 0.4 mcg/kg/hr IV infusion using IBW (may titrate based on patient response between 0.3-0.5mcg/kg/hr) * Lidocaine 2mg/kg/hr IV infusion using IBW * May use esmolol as needed to treat SBP or HR \> 20% of baseline * Neuromuscular blockade at the discretion of anesthesiology team Emergence * Dexmedetomidine infusion turned off during laparoscopic desufflation * Lidocaine infusion turned off at skin closure * Neuromuscular reversal, dosed according to VM protocol * Pt extubated and brought to PACU * PACU opioid orders per anesthesiology team Post-operative Nausea/Vomiting Prophylaxis -4mg dexamethasone, 1mg haloperidol, scopolamine patch
Primary Outcome Measures
NameTimeMethod
24 Hour Opioid Consumption24 hours

Total amount of opioid use within the first 24 hours after surgery in mg of oral morphine equivalent doses

Secondary Outcome Measures
NameTimeMethod
Length of Time Under General Anesthesia1-5 hours

Time from induction to emergence of anesthesia

Percentage of Patients With Opioid-related Adverse Effects24 hours

Adverse effects include postoperative nausea, vomiting, pruritis, and respiratory depression. Some subjective, patient-reported data collection failed; these participants were excluded from this outcome.

Length of Time to Recover From General Anesthesia1-3 hours

Time from arrival to PACU to "ready for PACU discharge"

Length of Hospital Stay1-5 days

Time from PACU arrival to discharge date and time in days

Overall Patient Satisfaction With Analgesia: Yes or no24 hours

Number of Participants With Overall Patient Satisfaction With Analgesia

Number of Participants With Post-surgical Opioid Prescription Refills up to 30 Days30 days

Number of participates with opioid prescription refills since surgery within 30 day after surgery

Percentage of Patients Treated for General Anesthetic Adverse EffectsIntraoperative, between time entering OR and PACU arrival time

Episodes of severe bradycardia or treated hypotension intraoperatively

Number of Participants With Post-surgical Opioid Prescription Refills Between 30 Days to 3 Months After Surgery3 months

Number of participates with opioid prescription refills since surgery between 30 day and 3 months after surgery

Trial Locations

Locations (1)

Virginia Mason Medical Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath